Clinical Trials Directory

Trials / Completed

CompletedNCT04404608

Etiology of Lymphopenia in Covid19 Infection

Study of the Etiology of Lymphopenia in Covid19 Viral Infection

Status
Completed
Phase
Study type
Observational
Enrollment
172 (actual)
Sponsor
Dr Medhat Khafagy · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Detailed description

Each cohort will include 30 patients. Complete blood count in all patients will be done daily in all patients. Bone marrow aspiration cytology will be done in some selected patients especially those with lymphopenia less than 1000 per cubic mm. Correlation of the degree of lymphopenia with the status of the patients will be done. Also correlation will be done about the relation of recovery of lymphopenia and status of the patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComplete blood picture, bone marrow aspiration cytologynone except the regular routine investigations in such cases

Timeline

Start date
2020-06-01
Primary completion
2021-06-01
Completion
2021-12-01
First posted
2020-05-27
Last updated
2022-07-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04404608. Inclusion in this directory is not an endorsement.